Assembly Biosciences
Clinical trials sponsored by Assembly Biosciences, explained in plain language.
-
New herpes drug shows promise in early safety trial
Disease control CompletedThis early-stage study tested a new drug called ABI-5366 in 115 people to see if it is safe and how the body processes it. The trial included healthy volunteers and people with recurrent genital herpes caused by HSV-2. The goal was to gather safety data and understand dosing, not…
Phase: PHASE1 • Sponsor: Assembly Biosciences • Aim: Disease control
Last updated May 17, 2026 13:55 UTC
-
New herpes drug ABI-1179 passes first safety check in small study
Symptom relief CompletedThis early-stage study tested a new drug called ABI-1179 in 103 people. First, healthy volunteers received a single dose to check safety. Then, people with recurrent genital herpes (caused by HSV-2) received multiple doses. The main goal was to see if the drug is safe and how the…
Phase: PHASE1 • Sponsor: Assembly Biosciences • Aim: Symptom relief
Last updated May 15, 2026 11:56 UTC
-
Healthy volunteers test new hepatitis d drug for safety
Knowledge-focused CompletedThis early-stage study tested the safety and how the body handles a new drug called ABI-6250 in 40 healthy adults. Participants received either the drug or a placebo, and researchers measured side effects and drug levels in the blood. The goal was to gather safety information bef…
Phase: PHASE1 • Sponsor: Assembly Biosciences • Aim: Knowledge-focused
Last updated May 17, 2026 13:55 UTC